FDA Approves Opill Daily Oral Contraceptive Targeting Low-Income Women, Teens, & Minority Groups

On Thursday (July 13, 2023) the Food and Drug Administration, approved its first every over-the-counter birth control pill in a landmark decision aimed at allowing more women and girls in the U.S. an alternative to prevent unintended pregnancies without prescription.

The Opill, otherwise known as the mini pill, is reported to contain only one progestin hormone whereas other pills on the market contain both progestin and estrogen. FDA’s Center for Drug Evaluation and Research director, Dr. Patrizia Cavazzoni, said in a press release:

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States. When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

Expected to make it on store shelves between January and March 2024, the minipill is being hailed as ‘historic’ among advocacy and medical groups; namely Free the Pill and the American College of Obstetricians and Gynecologists, which have been lobbying for years for an over-the-counter birth control pill.

Anti-abortion advocates such as Students for Life maintain the position: "Because our mission is to abolish abortion, Students for Life of America does not take a stance on the morality of non-abortifacient contraceptives' like hormonal birth control pills.” Adding, “While the intention of women who consume these types of birth control isn’t to end life but prevent the creation of new life, we believe in trusting the science and proceeding with caution.”

Yet the March for Life organization, organizers of an annual march on Washington D.C. event with thousands pro-life activists, argued for many years that hormonal birth control caused abortion. March for Life advocates believe that “the use of any birth control method that prevents the implantation of a fertilized egg in the womb is the equivalent of abortion.”

Raising concerns for alarm, the FDA’s Nonprescription Drugs Advisory Committee and the Reproductive and Urologic Drugs Advisory Committee are concerned about how obese women may be impacted by the Opill, since its initial study was conducted in 1960 when obesity statistics were closer to 13%. According to the research, “Obese women who take oral contraceptives have an increased risk of blood clots.”

Because the Opill will be an over-the-counter alternative, doctors will not have the opportunity to explain to patients the importance of taking the pill in proper daily dosages; presenting another reason for concern. Patrick Lockwood-Taylor, President and CEO of Opill said: “Opill has the potential to radically transform women's access to contraception.”

However, according to Dr. Sarah Hill, a psychologist specializing in women’s health, these altered hormones may re-wire brain circuits related to love and sex and serve as a gateway in transforming straight women into lesbians because of its ability to suppress the body’s natural production of sex hormones after replacing them with a synthetic version.

Visit http://SupportDiamondandSilk.com to Become a Monthly Supporter and support our many Affiliates who are working hard to create products for combating the growing issues facing our country.

Stay Connected to Diamond and Silk: Frank Speech, GETTR, TruthSocial, ChatDit, Rumble and Parler.

Be sure to visit the Diamond and Silk Store to get a gift for your loved ones. While you’re there be sure to check out the Diamond & Silk Natural Skin Care Line of products. Use Promo Code “Diamond” to take advantage of our special discounts.